| Value | ₹34.00 Cr |
|---|
BSE filing, NSE: GODAVARI. Summary written from the filing by ALFA Finder's alert engine.
Godavari Drugs Ltd: key numbers
- Share price
- ₹125.60
- Market cap
- ₹127.2 Cr
- Revenue (annual)
- ₹105.8 Cr
- Net profit (annual)
- ₹4.09 Cr
- P/E (TTM)
- 30.6×Sector 45.9×
- Promoter holding
- 40.23%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Godavari Drugs Ltd
All →Godavari Drugs Other Announcement
Godavari Drugs Limited changed its Corporate Identification Number (CIN) following an alteration to its Memorandum of Association's Object Clause. The Ministry of Corporate Affairs registered the change on October 16, 2026.
Godavari Drugs Annual General Meeting
Godavari Drugs held its 38th Annual General Meeting on September 25, 2026, via video conferencing. Shareholders approved financial statements, director re-appointment, and object clause alteration.
Godavari Drugs Annual General Meeting
Godavari Drugs Limited will close its register of members and share transfer books from September 19 to September 25, 2026, for its 38th Annual General Meeting.
Godavari Drugs Board Meeting Outcome
Godavari Drugs approved altering its Memorandum of Association to add a nutraceuticals business object. A revised notice for the 38th AGM was also approved.
Godavari Drugs Capital Structure Change
Godavari Drugs Limited allotted 7,86,690 equity shares to the promoter category following warrant conversion. The company received Rs. 5.25 Crore, representing the final 75% payment.
- Value
- ₹5.25 Cr
Godavari Drugs Q1 FY27 Results: Net Profit ₹1.1 Cr, Up 10.0% YoY
Godavari Drugs Ltd reported revenue from operations of ₹28 Cr (+17.6% YoY) and net profit of ₹1.1 Cr (+10.0% YoY) for Q1 FY27.
- Key figure
- Net profit ₹1.1 Cr · +10.0% YoY
Other debt & borrowing announcements
All →Magnum Ventures Debt & Borrowing: ₹1.65 Cr
Magnum Ventures paid Rs 1.65 Crore monthly NCD interest across two series on time. Payment was made October 26, 2026, ahead of the October 31 due date.
- Value
- ₹1.65 Cr
Sadhav Shipping Debt & Borrowing: ₹10 Cr
Sadhav Shipping approved a Rs. 10 crore term loan from Bajaj Finance Limited, secured against vessel AHTS Saroja Blessing. It carries 9.75% interest over 48 months.
- Value
- ₹10.00 Cr
- Execution
- 48 months, including a 3-month moratorium
Sakthi Finance Debt & Borrowing: ₹3.29 Cr
Sakthi Finance certified timely payment of ₹3.29 Crore monthly interest across 17 NCD tranches for October 2026. All payments were made on the due date.
- Value
- ₹3.29 Cr
Capri Global Capital Debt & Borrowing: ₹50 Cr
Capri Global Capital redeemed ₹50 Crore of BSE-listed Commercial Paper at maturity on November 2, 2026. The filing confirms timely principal payment with NIL outstanding interest.
- Value
- ₹50.00 Cr
Dar Credit & Capital Debt & Borrowing: ₹0.1 Cr
Dar Credit & Capital paid Rs. 0.10 Crore monthly interest on NCD INE04Q907207. Payment made 02 Nov 2026 as due date fell on a weekend.
- Value
- ₹0.10 Cr
Shriram Finance Debt & Borrowing: ₹3.98 Cr
Shriram Finance confirmed timely payment of monthly interest on four NCD series totaling ₹3.98 Crore. Payments were made on 2 November 2026 under Reg 57(1) LODR compliance.
- Value
- ₹3.98 Cr